Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

The relevance of age in female human reproduction--current situation in Switzerland and pathophysiological background from a comparative perspective.

Leeners B, Geraedts K, Imthurn B, Stiller R.

Gen Comp Endocrinol. 2013 Jul 1;188:166-74. doi: 10.1016/j.ygcen.2013.02.035. Epub 2013 Mar 21.

PMID:
23523998
2.

Assisted reproductive technology surveillance--United States, 2000.

Wright VC, Schieve LA, Reynolds MA, Jeng G.

MMWR Surveill Summ. 2003 Aug 29;52(9):1-16. Erratum in: MMWR 2003 Oct 3; 52(39):942.

3.

Assisted reproductive technology surveillance--United States, 2009.

Sunderam S, Kissin DM, Flowers L, Anderson JE, Folger SG, Jamieson DJ, Barfield WD; Centers for Disease Control and Prevention (CDC)..

MMWR Surveill Summ. 2012 Nov 2;61(7):1-23.

4.

Assisted reproductive technology surveillance--United States, 2001.

Wright VC, Schieve LA, Reynolds MA, Jeng G, Kissin D.

MMWR Surveill Summ. 2004 Apr 30;53(1):1-20.

5.

Assisted reproductive technology surveillance - United States, 2004.

Wright VC, Chang J, Jeng G, Chen M, Macaluso M; Centers for Disease Control and Prevention..

MMWR Surveill Summ. 2007 Jun 8;56(6):1-22. Erratum in: MMWR Morb Mortal Wkly Rep. 2007 Jul 6;56(26):658.

6.

Assisted reproductive technology surveillance--United States, 2005.

Wright VC, Chang J, Jeng G, Macaluso M; Centers for Disease Control and Prevention (CDC)..

MMWR Surveill Summ. 2008 Jun 20;57(5):1-23. Erratum in: MMWR Surveill Summ. 2009 Mar 6;58(8):203-4. MMWR Surveill Summ. 2008 Oct 10;57(40):1105.

7.

Assisted reproductive technology surveillance--United States, 2006.

Sunderam S, Chang J, Flowers L, Kulkarni A, Sentelle G, Jeng G, Macaluso M; Centers for Disease Control and Prevention (CDC)..

MMWR Surveill Summ. 2009 Jun 12;58(5):1-25.

8.

Reproductive potential in the older woman.

Gindoff PR, Jewelewicz R.

Fertil Steril. 1986 Dec;46(6):989-1001. Review.

PMID:
3536609
9.

Correlation of age and antimullerian hormone in assisted reproductive technology program outcome.

Himabindu Y, Gopinathan KK, Pandey AK, Sriharibabu M.

Indian J Physiol Pharmacol. 2013 Jan-Mar;57(1):9-15.

PMID:
24020093
10.
11.
12.

Assisted reproductive technology surveillance--United States, 2003.

Wright VC, Chang J, Jeng G, Macaluso M.

MMWR Surveill Summ. 2006 May 26;55(4):1-22.

13.

Incidence of depression and influence of depression on the number of treatment cycles and births in a national cohort of 42,880 women treated with ART.

Sejbaek CS, Hageman I, Pinborg A, Hougaard CO, Schmidt L.

Hum Reprod. 2013 Apr;28(4):1100-9. doi: 10.1093/humrep/des442. Epub 2013 Jan 8.

PMID:
23300199
14.

Impact of female age and male infertility on ovarian reserve markers to predict outcome of assisted reproduction technology cycles.

Lee TH, Liu CH, Huang CC, Hsieh KC, Lin PM, Lee MS.

Reprod Biol Endocrinol. 2009 Sep 17;7:100. doi: 10.1186/1477-7827-7-100.

15.

Assisted reproductive technology surveillance--United States, 2002.

Wright VC, Schieve LA, Reynolds MA, Jeng G; Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention (CDC)..

MMWR Surveill Summ. 2005 Jun 3;54(2):1-24.

16.

The prognostic value of basal luteinizing hormone:follicle-stimulating hormone ratio in the treatment of patients with polycystic ovarian syndrome by assisted reproduction techniques.

Tarlatzis BC, Grimbizis G, Pournaropoulos F, Bontis J, Lagos S, Spanos E, Mantalenakis S.

Hum Reprod. 1995 Oct;10(10):2545-9.

PMID:
8567767
17.

Live birth chances in women with extremely low-serum anti-Mullerian hormone levels.

Weghofer A, Dietrich W, Barad DH, Gleicher N.

Hum Reprod. 2011 Jul;26(7):1905-9. doi: 10.1093/humrep/der134. Epub 2011 Apr 30.

PMID:
21531994
18.

Outcomes of assisted reproductive technologies at the Nairobi In Vitro Fertilisation Centre.

Noreh LJ, Tucs O, Sekadde-Kigondu CB, Noreh JA.

East Afr Med J. 2009 Apr;86(4):156-61.

PMID:
20084998
19.

Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatment.

Peñarrubia J, Fábregues F, Manau D, Creus M, Casals G, Casamitjana R, Carmona F, Vanrell JA, Balasch J.

Hum Reprod. 2005 Apr;20(4):915-22. Epub 2005 Jan 21.

PMID:
15665015
20.

Comparative birth weights of singletons born after assisted reproduction and natural conception in previously infertile women.

De Geyter C, De Geyter M, Steimann S, Zhang H, Holzgreve W.

Hum Reprod. 2006 Mar;21(3):705-12. Epub 2005 Nov 10.

PMID:
16284064

Supplemental Content

Support Center